TRT and FSH Suppression: Impact on Male Fertility and Testicular Function
Written by Adam Maggio | Medically reviewed by Dr. Mitchell Ross, MD, ABAARM
Testosterone Replacement Therapy (TRT) inevitably leads to the suppression of Follicle-Stimulating Hormone (FSH) from the pituitary gland. This suppression directly impairs spermatogenesis, making it a critical consideration for men concerned with their reproductive capacity.
TRT and FSH Suppression: Impact on Male Fertility and Testicular Function
One of the most significant, yet often overlooked, consequences of Testosterone Replacement Therapy (TRT) is the suppression of Follicle-Stimulating Hormone (FSH). FSH, a gonadotropin produced by the pituitary gland, plays a pivotal role in male reproductive health, primarily by stimulating the Sertoli cells within the testes. These cells are the "nurse cells" of the testes, essential for supporting the development and maturation of sperm, a process known as spermatogenesis. When you introduce exogenous testosterone, your body's intricate feedback system interprets this as sufficient testosterone, leading to a reduction in FSH output.
This suppression isn't a minor side effect; it's a direct physiological response. The hypothalamic-pituitary-gonadal (HPG) axis, which regulates testosterone and sperm production, is highly sensitive to circulating androgen levels. High levels of exogenous testosterone signal the hypothalamus to decrease Gonadotropin-Releasing Hormone (GnRH) and the pituitary to reduce both Luteinizing Hormone (LH) and FSH. The consequence is a significant disruption to the natural processes governing male fertility.
The Mechanism of FSH Suppression
Exogenous testosterone directly inhibits the pituitary gland's release of FSH. Studies, including those by Masterson et al. (2021) [1], have demonstrated that TRT, particularly longer-acting preparations, leads to a substantial decrease in serum FSH levels. This suppression is often profound, with FSH levels dropping to near undetectable ranges in many men on therapy. The degree of suppression can vary, but the general trend is a significant reduction from baseline.
The primary impact of suppressed FSH is on the Sertoli cells. Without adequate FSH stimulation, these cells cannot effectively nurture developing sperm. This leads to impaired spermatogenesis, resulting in reduced sperm count (oligozoospermia) or even a complete absence of sperm (azoospermia). For men who are not concerned with future fertility, this suppression may be an acceptable trade-off for the benefits of TRT. However, for those who wish to maintain their reproductive potential, FSH suppression is a critical concern.
Navigating the Nuances: Fertility and TRT
For men actively seeking to preserve fertility while on TRT, the suppression of FSH presents a significant challenge. Unlike LH, which can be mimicked by HCG to stimulate Leydig cells, there isn't a direct pharmacological equivalent to FSH that can be easily co-administered to maintain spermatogenesis without also stimulating endogenous testosterone production (which would then further suppress the HPG axis). However, some protocols utilize Human Chorionic Gonadotropin (HCG) to maintain intratesticular testosterone levels, which is also crucial for Sertoli cell function, even in the face of suppressed FSH [2]. While HCG primarily acts like LH, the presence of sufficient intratesticular testosterone is vital for the overall health and function of the seminiferous tubules where sperm are produced.
It's important to note that the recovery of spermatogenesis after discontinuing TRT can be a lengthy process, often taking many months, and in some cases, full recovery may not occur [3]. This is due to the prolonged suppression of the HPG axis, including FSH, which needs time to reactivate and restore normal function.
Comparison: FSH Levels and Fertility Impact
| Condition | FSH Levels | Spermatogenesis | Fertility Impact |
|---|---|---|---|
| Healthy Male (No TRT) | Normal, pulsatile | Active and robust | Maintained |
| On TRT (No HCG) | Suppressed (often undetectable) | Impaired or ceased | Often severely impaired |
| On TRT (With HCG) | Suppressed (pituitary still affected) | Potentially preserved (due to intratesticular T) | Variable, but often better than TRT alone |
Practical Takeaway
If you're on TRT, understand that your FSH levels will likely be suppressed, directly impacting your body's ability to produce sperm. If fertility is a concern, discuss this thoroughly with your practitioner. While direct FSH replacement isn't common, strategies like HCG can help maintain intratesticular testosterone, which is vital for supporting spermatogenesis despite FSH suppression.
References
- Masterson, T. A., et al. (2021). The Effect of Longer-Acting vs Shorter-Acting Testosterone Preparations on Follicle-Stimulating Hormone and Luteinizing Hormone Suppression. The Journal of Sexual Medicine, 18(1), 163-170.
- Lee, J. A. (2018). Indications for the use of human chorionic gonadotropic. Translational Andrology and Urology, 7(4), 601â608.
- DrOracle.ai. (n.d.). What happens to Follicle-Stimulating Hormone (FSH) and Luteinizing Hormone (LH) during Testosterone Replacement Therapy (TRT)?